London, UK 20 February 2007: BTG plc (LSE: BGC), the medical innovations company, today announces that it has acquired an opioid agonist for the control of post-operative pain from CLL Pharma, the drug development company based in Nice, France, in return for undisclosed milestone and royalty payments.
